title: [Acute myeloblastic leukemia during pregnancy].
abstract: We present a pregnant woman, with diagnosis of acute myeloblastic leukemia (AML) established in the third trimester of pregnancy. She was delivered by Caesarean section at the end of 36th gestational week, and a healthy, mature-for-date, male infant was born. Combined chemotherapy (YU-AML protocol) was administered a week after the delivery, but the patient died after 7 months, due to resistant disease. We discuss actual problems that make an approach to pregnant patient with AML specific and individual.
authors.affiliation: Institute of Hematology, Clinical Centre of Sebia, Belgrade.
authors.forename: N
authors.initials: N
authors.lastname: Radosević-Radojković
authors.forename: D
authors.initials: D
authors.lastname: Bosković
authors.forename: B
authors.initials: B
authors.lastname: Lazarević
authors.forename: I
authors.initials: I
authors.lastname: Elezović
authors.forename: R
authors.initials: R
authors.lastname: Tomashević
authors.forename: Z
authors.initials: Z
authors.lastname: Rolović
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents